Your questions
It does. The peculiarity of the Arecur® medicine is that it ensures the maximum effectiveness of immunity in the destruction of viruses, bacteria, and tumor cells.
No, it’s not. Arecur® is an immunocorrector. It is known that immunomodulators have a non-specific effect on immunity, they are often used unreasonably, which leads to the immunity reserves depletion. The unique difference of the Arecur® immunocorrector is that it purposefully adjusts the activity of the immune system against tumors and infections, acts powerfully, safely, and most importantly - preserves the body's reserves. This is very important in case of oncology and other serious diseases.
Stimulating the active work of a woman's immune cells, Arecur® ensures the synthesis of immunoglobulin A - the main weapon against the human papilloma virus (HPV), herpes viruses, and chlamydia. This active protein destroys the infection, prevents the development of dysplasia.
Extensive clinical experience shows that including Arecur® in treatment patients with breast cancer reduces the risk of relapses and metastases by 56%.
Arecur® strengthens the immune system and helps the body to cope with intoxication caused by the death of tumor cells.
Thrush often recurs due to the resistance of the fungus to antibiotics and the decrease of the woman's immunity. In this case, Arecur® is an optimal and balanced solution. Stimulating the active work of a woman's immune cells, Arecur® ensures the synthesis of immunoglobulin A, which is the main weapon against the Candida fungi. This active protein destroys the infection and prevents possible relapses. For effective immunocorrection in a case of thrush, Arecur® vaginal suppositories are used: 1 suppository 2 times a day for 10 days.
The most common treatment scheme for fibromyoma treatment in gynecological practice is 1 ampoule intravenously once a day in the morning and 1 suppository vaginally once a day in the evening for 20 days; 10-day-break, then repeat the course.
Yes, it will definitely be. The appointment of Arecur® in a case of leukoplakia is clinically justified: firstly, this is the necessary work of T-lymphocytes and macrophages against atypical cells in the epithelial layer, which is already subject to metaplasia, secondly, this is the direct effect of immune peptides on the focus of disease and prevention of its progression, this is the reduction of perifocal inflammation and normalization of microbiota. To achieve a clinically significant effect of Arecur® in case of leukoplakia, two 20-day courses of suppositories with a break of 10 days are... Read more
They are: allergic status, bronchial asthma, vasculitis, rheumatoid arthritis in the exacerbation phase, sepsis, endocarditis, myocarditis, acute and chronic glomerulonephritis, hemoblastosis, lymphomas; period of pregnancy and breastfeeding; children's age up to 12 years.
Infusions of 200 ml, injections of 2 ml are medicine. Suppositories 2.0 g are medical products. Capsules 260 mg are dietary supplement. Ointment 25 g is a cosmetic product.
Yes, it was. Approximately 3% of patients on the 2nd-3rd day of using immunocorrection may have the symptoms of a viral infection: fever, joint pain, weakness, body aches.
These reactions are associated with the activation of immune cells, which disappear the next day without any special treatment.
Yes, it is. Immunocorrection is fully compatible with classical chemotherapy and hormone therapy. The most common standard scheme is 1 ampoule intravenously once a day/ or 1 inhalation once a day for 20 days. A more gentle scheme of escalating immunocorrection is also possible: 1 capsule 2 times a day for a month, then 1 ampoule intravenously once a day for 20 days. Antirelapse immunocorrection involves 2 to 4 courses per year. It is important that inhalations cannot be carried when the person has got a high temperature and on the same day when cisplatin/oxaliplatin were injected due to their... Read more
